Ulrich Schmid re-elected Chairman of the VDGH Executive Board

Back

The General Assembly of the Association of the Diagnostics Industry (VDGH) has confirmed Ulrich Schmid (A. Menarini Diagnostics Germany) in his position as Chairman of the Board. Schmid, who has held the role since 2018, was elected to the position for a further two years at today's meeting in Berlin.

"We have a wide range of challenges that we will continue to tackle with commitment in the new Executive Board. Our three biggest issues for the future are the digitalization of the healthcare sector, the existing shortage of skilled workers and the continuing shortcomings in the implementation of the IVDR. We will actively support the revision with strong partners in a national alliance," explains Schmid.

Dr. Thorsten Hilbich (DiaSorin Deutschland GmbH), Deputy Chairman of the Executive Board, was also confirmed in office. Dirk Schick (Roche Diagnostics Deutschland GmbH) completes the management trio as the new treasurer.

Stefanie Giesener (DiaSys Diagnostic Systems GmbH) and Dr. Peter Schüßler (Bio-Techne GmbH) were also re-elected. New to the Board are Dr. Liane Bauer (Abbott GmbH), Dr. Anika Jöcker (Cepheid GmbH), Dr. Anette Leue (Promega GmbH) and Dr. Matthias Probst (QIAGEN GmbH).

The newly elected and confirmed board members are looking forward to the challenges ahead and continuing their work in the VDGH.

In a nutshell: The Association of the Diagnostics Industry (VDGH)

The Association of the Diagnostics Industry (VDGH) is a trade association representing the interests of more than 100 companies operating in Germany with a total turnover of 5.5 billion euros in 2024. They manufacture examination systems and reagents for the diagnosis of human diseases, which generate a turnover of more than 2.4 billion euros, as well as instruments, reagents, test systems and consumables for research in the life sciences, which generate a turnover of 3.1 billion euros.

www.vdgh.de